MedTrace Logo

Vitamin C as add-on Therapy in Patients With Acute Herpes Zoster

NCT05561257 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2024-11-07

No results posted yet for this study

Summary

To compare the efficacy and tolerability of three different doses of Pascorbin® besides standard medication with placebo and the reduction of herpes zoster-associated clinical symptoms as an add-on therapy for patients suffering from acute herpes zoster in primary care

Conditions

  • Neuropathic Pain

Interventions

DRUG

Vitamin C

Vitamin C

Sponsors & Collaborators

  • Pascoe Pharmazeutische Praeparate GmbH

    lead INDUSTRY

Principal Investigators

  • Holger Michels · Pascoe Pharmazeutische Praeparate GmbH

  • Andraes Pinter, Dr. · Universitätsklinik Frankfurt am Main

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-20
Primary Completion
2024-02-28
Completion
2024-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05561257 on ClinicalTrials.gov